ReaGenics CEO Presents to NYC Investors – Sept. 12th 2019

ReaGenics CEO Presents to NYC Investors – Sept. 12th 2019

Sept. 12th, NEW YORK – ReaGenics is proud to have presented at iCAN’s first-ever Israeli Cannabis Investor Symposium in NYC! iCANconnect provided over 130 investors the opportunity to learn about the innovative Israeli cannabis industry, meet executives and researchers and evaluate investment opportunities. 

As the US moves into the post-prohibition era, Israeli cannabis industry leadership will contribute to the health and growth of the industry. iCANconnect brings the best of Israel to qualified investors and other stakeholders in select locations around the world – and where better to launch than the Big Apple?

Ten Israeli cannabis startups included a presentation by Michael Kagan, CEO of ReaGenics, offering the opportunity to invest in his innovative process for growing cannabinoid cells in bioreactors on a mass scale, negating all the obstacles of growing a physical plant.